Biochemical investigations demonstrated persistent hypercalcemia, elevated parathyroid hormone, and significantly raised fasting gastrin levels whilst off high-dose PPI, raising suspicion for MEN1 syndrome. The gene discussed is PTH; the disease is multiple endocrine neoplasia type 1.